Clinical Research Advances in Non-alcoholic Fatty Liver Disease
A special issue of Journal of Clinical Medicine (ISSN 2077-0383). This special issue belongs to the section "Gastroenterology & Hepatopancreatobiliary Medicine".
Deadline for manuscript submissions: closed (21 May 2023) | Viewed by 22156
Special Issue Editor
Interests: liver transplant; non-alcoholic fatty liver disease; obesity; irritable bowel syndrome
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Nonalcoholic fatty liver disease (NAFLD) is rapidly becoming the most common cause of chronic liver disease in Western countries and is likely to be the most common cause of liver transplantation in the coming years. The prevalence of NAFLD is very high (up to 60%) in patients with type 2 diabetes or obesity, especially in candidates for bariatric surgery. NAFLD has been strongly associated with Metabolic syndrome. However, there is growing evidence of a more complex pathophysiology in which pro-inflammatory pathways play a key role. Therefore, NAFLD can be considered a multisystem disease that requires multidisciplinary assessment.
The aim of this Special Issue is to address the multiple aspects of NAFLD as a new indication for liver transplantation, highlighting the impact of associated comorbidities and recent advances in optimal treatment and therapies for these patients.
Dr. Antonella Santonicola
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Journal of Clinical Medicine is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- nonalcoholic fatty liver disease
- liver transplantation